Oral heparin results in the appearance of heparin fragments in the plasma of rats.
We have previously shown that angiogenesis inhibition and tumor regression can be accomplished by combinations of heparin or heparin fragments with cortisone [Folkman, J., Langer, R., Linhardt, R. J., Haudenschild, C. & Taylor, S. (1983) Science 221, 719-725]. Oral heparin was also effective in combination with cortisone. We now show that a single oral dose of [35S]heparin or [3H]heparin (15,000 units/kg) results in continuous release of radioactive material into the bloodstream for at least 12 hr. This is associated with the presence of anti-factor Xa activity at a level of approximately equal to 0.1 unit/ml. The radioactive material is identified as oligo-, di-, and monosaccharides by its behavior in chromatographic systems, its possession of anti-factor Xa activity, and the effect of treatment with bacterial heparinase. The heparin fragments are extensively metabolized to fragments without anti-factor Xa activity that are readily subject to urinary excretion.
Larsen
A K
AK
Lund
D P
DP
Langer
R
R
Folkman
J
J
D000284:Administration, Oral; D000818:Animals; D004187:Disaccharides / Q000097:blood; D005170:Factor X / Q000037:antagonists & inhibitors; D015951:Factor Xa; D006493:Heparin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D008297:Male; D009005:Monosaccharides / Q000097:blood; D009844:Oligosaccharides / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains; D013462:Sulfur Radioisotopes; D013927:Thrombosis / Q000517:prevention & control; D014316:Tritium
D004187:Disaccharides; D009005:Monosaccharides; D009844:Oligosaccharides; D013462:Sulfur Radioisotopes; D014316:Tritium; D005170:Factor X; D006493:Heparin; D015951:Factor Xa